Corcept Therapeutics
CORT
#2487
Rank
S$9.44 B
Marketcap
S$88.02
Share price
0.85%
Change (1 day)
-11.87%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): S$8.95 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are S$0.76 Billion. In 2025 the company made an earning of S$84.83 Million a decrease over its 2024 earnings that were of S$0.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$8.95 M-89.44%
2025 S$84.83 M-58.84%
2024 S$0.20 B29.65%
2023 S$0.15 B7.2%
2022 S$0.14 B-7.05%
2021 S$0.15 B-5.01%
2020 S$0.16 B12.79%
2019 S$0.14 B26.61%
2018 S$0.11 B74.51%
2017 S$67.4 M548.72%
2016 S$10.38 M-227.03%
2015 -S$8.18 Million-79.58%
2014 -S$40.06 Million-31.79%
2013 -S$58.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.15 B 358,527.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.14 B 217,790.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$13.51 B 146,103.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.72 B 429,565.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.78 B 181,457.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.24 B 132,382.05%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$1.79 M-80.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$35.03 Million-478.81%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.49 B 5,222.94%๐Ÿ‡บ๐Ÿ‡ธ USA